Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › IONS
DEERFIELD MANAGEMENT COMPANY, L.P. position in IONS
IONIS PHARMACEUTICALS INC · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 60,000,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$93.1M, representing 1.17% of its reported portfolio and ranking #26 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s IONS position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in IONS in Q3 2025 at 60,000,000 shares (US$82.7M). The position peaked in Q4 2025 at 60,000,000 shares, worth US$95.3M. Across 4 filings, DEERFIELD MANAGEMENT COMPANY, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 60,000,000 shares valued at US$93.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 60.00M | $82.66M | New |
| Q4 2025 | 60.00M | $95.33M | Hold |
| Q1 2026 | 60.00M | $90.61M | Hold |
| Q2 2026 | 60.00M | $93.10M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M sh · $180.81M · Q2 2026
- Deep Track Capital, LP 2.20M sh · $174.44M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K sh · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K sh · $52.70M · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held IONS?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed IONS holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in IONS?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 60.00M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $93.10M, representing 1.17% of its reported portfolio and ranking #26.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling IONS?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in IONS. The position peaked in Q4 2025 at 60.00M shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.